Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,615.00
-125.00 (-4.56%)
At close: Jun 8, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 52.71 billion as of June 8, 2026. Its market cap has decreased by -23.46% in one year.
Market Cap
52.71B
Enterprise Value
51.65B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,615.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 52.71B, a decrease of -79.30%. That is a compound annual growth rate of -23.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 50.30B | -32.60% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 63.98B |
| IMGT Co.,Ltd. | 62.02B |
| TegoScience | 61.09B |
| Progen | 53.81B |
| Aptamer Sciences | 52.07B |
| Quratis | 47.71B |
| ADBiotech | 46.15B |
| J2KBIO | 45.67B |